The E3 ubiquitin ligase HUWE1 is required for KRAS-induced lung cancer.

Saved in:
Bibliographic Details
Title: The E3 ubiquitin ligase HUWE1 is required for KRAS-induced lung cancer.
Authors: Searle J; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK. Joshua.searle@ucl.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK. Joshua.searle@ucl.ac.uk.; Lungs for Living Research Centre, UCL Respiratory, Division of Medicine, University College London (UCL), London, UK. Joshua.searle@ucl.ac.uk., Menotti M; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK., McDaid WJ; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Baker MJ; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Chaturvedi A; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK., Ginn L; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK., Reed H; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK., Carter M; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK., Blackhall F; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK., Lindsay CR; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK., Malliri A; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK. angeliki.malliri@manchester.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK. angeliki.malliri@manchester.ac.uk.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. angeliki.malliri@manchester.ac.uk.
Source: Cell death & disease [Cell Death Dis] 2026 Apr 07; Vol. 17 (1). Date of Electronic Publication: 2026 Apr 07.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41942468
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The E3 ubiquitin ligase HUWE1 is required for KRAS-induced lung cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Searle+J%22">Searle J</searchLink>; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK. Joshua.searle@ucl.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK. Joshua.searle@ucl.ac.uk.; Lungs for Living Research Centre, UCL Respiratory, Division of Medicine, University College London (UCL), London, UK. Joshua.searle@ucl.ac.uk.<br /><searchLink fieldCode="AU" term="%22Menotti+M%22">Menotti M</searchLink>; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22McDaid+WJ%22">McDaid WJ</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Baker+MJ%22">Baker MJ</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Chaturvedi+A%22">Chaturvedi A</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Ginn+L%22">Ginn L</searchLink>; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Reed+H%22">Reed H</searchLink>; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Carter+M%22">Carter M</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Blackhall+F%22">Blackhall F</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Lindsay+CR%22">Lindsay CR</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Malliri+A%22">Malliri A</searchLink>; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK. angeliki.malliri@manchester.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK. angeliki.malliri@manchester.ac.uk.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. angeliki.malliri@manchester.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101524092%22">Cell death & disease</searchLink> [Cell Death Dis] 2026 Apr 07; Vol. 17 (1). <i>Date of Electronic Publication: </i>2026 Apr 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101524092 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-4889 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Death Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41942468
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41419-026-08672-7
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: The E3 ubiquitin ligase HUWE1 is required for KRAS-induced lung cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Searle J
      – PersonEntity:
          Name:
            NameFull: Menotti M
      – PersonEntity:
          Name:
            NameFull: McDaid WJ
      – PersonEntity:
          Name:
            NameFull: Baker MJ
      – PersonEntity:
          Name:
            NameFull: Chaturvedi A
      – PersonEntity:
          Name:
            NameFull: Ginn L
      – PersonEntity:
          Name:
            NameFull: Reed H
      – PersonEntity:
          Name:
            NameFull: Carter M
      – PersonEntity:
          Name:
            NameFull: Blackhall F
      – PersonEntity:
          Name:
            NameFull: Lindsay CR
      – PersonEntity:
          Name:
            NameFull: Malliri A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 04
              Text: 2026 Apr 07
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2041-4889
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cell death & disease
              Type: main
ResultId 1